Literature DB >> 24810623

Abnl(17p) in AML: who will guard the guardian?

Minoo Battiwalla1.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 24810623      PMCID: PMC4014835          DOI: 10.1182/blood-2014-04-565515

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

1.  Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.

Authors:  Jan M Middeke; Min Fang; Jan J Cornelissen; Brigitte Mohr; Frederick R Appelbaum; Michael Stadler; Jaime Sanz; Herrad Baurmann; Gesine Bug; Kerstin Schäfer-Eckart; Ute Hegenbart; Tilmann Bochtler; Christoph Röllig; Friedrich Stölzel; Roland B Walter; Gerhard Ehninger; Martin Bornhäuser; Bob Löwenberg; Johannes Schetelig
Journal:  Blood       Date:  2014-03-20       Impact factor: 22.113

2.  TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis.

Authors:  D Bowen; M J Groves; A K Burnett; Y Patel; C Allen; C Green; R E Gale; R Hills; D C Linch
Journal:  Leukemia       Date:  2008-07-03       Impact factor: 11.528

Review 3.  Therapeutic targeting of the p53 pathway in cancer stem cells.

Authors:  Varun V Prabhu; Joshua E Allen; Bo Hong; Shengliang Zhang; Hairong Cheng; Wafik S El-Deiry
Journal:  Expert Opin Ther Targets       Date:  2012-09-24       Impact factor: 6.902

4.  Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3/ITD outweighs the conventional markers.

Authors:  S M Sengsayadeth; M Jagasia; B G Engelhardt; A Kassim; S A Strickland; S Goodman; C Lucid; C L Vnencak-Jones; J P Greer; B N Savani
Journal:  Bone Marrow Transplant       Date:  2012-06-04       Impact factor: 5.483

Review 5.  p53 mutations in human cancers.

Authors:  M Hollstein; D Sidransky; B Vogelstein; C C Harris
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

6.  A novel hierarchical prognostic model of AML solely based on molecular mutations.

Authors:  Vera Grossmann; Susanne Schnittger; Alexander Kohlmann; Christiane Eder; Andreas Roller; Frank Dicker; Christoph Schmid; Clemens-Martin Wendtner; Peter Staib; Hubert Serve; Karl-Anton Kreuzer; Wolfgang Kern; Torsten Haferlach; Claudia Haferlach
Journal:  Blood       Date:  2012-08-20       Impact factor: 22.113

7.  Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.

Authors:  Timothy J Ley; Christopher Miller; Li Ding; Benjamin J Raphael; Andrew J Mungall; A Gordon Robertson; Katherine Hoadley; Timothy J Triche; Peter W Laird; Jack D Baty; Lucinda L Fulton; Robert Fulton; Sharon E Heath; Joelle Kalicki-Veizer; Cyriac Kandoth; Jeffery M Klco; Daniel C Koboldt; Krishna-Latha Kanchi; Shashikant Kulkarni; Tamara L Lamprecht; David E Larson; Ling Lin; Charles Lu; Michael D McLellan; Joshua F McMichael; Jacqueline Payton; Heather Schmidt; David H Spencer; Michael H Tomasson; John W Wallis; Lukas D Wartman; Mark A Watson; John Welch; Michael C Wendl; Adrian Ally; Miruna Balasundaram; Inanc Birol; Yaron Butterfield; Readman Chiu; Andy Chu; Eric Chuah; Hye-Jung Chun; Richard Corbett; Noreen Dhalla; Ranabir Guin; An He; Carrie Hirst; Martin Hirst; Robert A Holt; Steven Jones; Aly Karsan; Darlene Lee; Haiyan I Li; Marco A Marra; Michael Mayo; Richard A Moore; Karen Mungall; Jeremy Parker; Erin Pleasance; Patrick Plettner; Jacquie Schein; Dominik Stoll; Lucas Swanson; Angela Tam; Nina Thiessen; Richard Varhol; Natasja Wye; Yongjun Zhao; Stacey Gabriel; Gad Getz; Carrie Sougnez; Lihua Zou; Mark D M Leiserson; Fabio Vandin; Hsin-Ta Wu; Frederick Applebaum; Stephen B Baylin; Rehan Akbani; Bradley M Broom; Ken Chen; Thomas C Motter; Khanh Nguyen; John N Weinstein; Nianziang Zhang; Martin L Ferguson; Christopher Adams; Aaron Black; Jay Bowen; Julie Gastier-Foster; Thomas Grossman; Tara Lichtenberg; Lisa Wise; Tanja Davidsen; John A Demchok; Kenna R Mills Shaw; Margi Sheth; Heidi J Sofia; Liming Yang; James R Downing; Greg Eley
Journal:  N Engl J Med       Date:  2013-05-01       Impact factor: 91.245

8.  Comparative analysis of the value of allogeneic hematopoietic stem-cell transplantation in acute myeloid leukemia with monosomal karyotype versus other cytogenetic risk categories.

Authors:  Jan J Cornelissen; Dimitri Breems; Wim L J van Putten; Alois A Gratwohl; Jakob R Passweg; Thomas Pabst; Johan Maertens; H Berna Beverloo; Marinus van Marwijk Kooy; Pierre W Wijermans; Bart J Biemond; Edo Vellenga; Leo F Verdonck; Gert J Ossenkoppele; Bob Löwenberg
Journal:  J Clin Oncol       Date:  2012-05-07       Impact factor: 44.544

9.  The prognostic impact of 17p (p53) deletion in 2272 adults with acute myeloid leukemia.

Authors:  H Seifert; B Mohr; C Thiede; U Oelschlägel; U Schäkel; T Illmer; S Soucek; G Ehninger; M Schaich
Journal:  Leukemia       Date:  2009-01-08       Impact factor: 11.528

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.